Intuitive Surgical Outperformance
"I got to talk about ISRG. We're talking about in uh intuitive surgical, the maker of the Da Vinci surgical robot. Yeah, this one it is uh outperforming in a big way. I was just double checking because it is a top performer, number one gainer in the S&P 500 and NASDAQ 100. That stock as we speak right now is up about 14%. It was up as much as 19% intraday, but right now with a gain of more than 14%. Uh the company boosted its worldwide Da Vinci procedure growth forecast for the full year. It's all about that. So more people using that's a good thing for the company."
The speaker highlights Intuitive Surgical (ISRG) as a top performer that has surged by around 14% intraday, driven by an upgraded worldwide growth forecast for its Da Vinci surgical robot. The commentary underscores strong operational performance amid prior stock pressure.
Intuitive Surgical Outperformance Commentary
"Yeah, right. Big pressure, lots of pressure. Uh having said that, uh Intuitive Surgical definitely an outperformer, guys. Top in the S&P and NASDAQ. Uh the robotic surgery company, you know them well, finishing the day just shy of a 14% gain. Uh the company did boost its uh worldwide Da Vinci procedure growth forecast for the year. So you know I used one of those once. I know. We're so glad. I mean I didn't personally use it but I was used on me. Yeah, and I guess it went well."
The speaker highlights Intuitive Surgical as a top performer, noting its nearly 14% gain and an upward revision in its worldwide Da Vinci procedure growth forecast. The commentary provides positive catalyst details and reinforces the company’s strong performance in the robotics surgery sector.
Intuitive Surgical Beats with Upgraded Forecast
"Intuitive Surgical is ISRG. That's a ticker there. This is a medical equipment company. Also, some earnings here of course as we're kind of parsing earnings season right now. The company uh boosted its worldwide Da Vinci pro procedure growth forecast for the full year. This essentially is a procedure that involves a robotic arm here that they use um during these surgeries. And so they did boost the forecast for growth there for the full year. And you are seeing shares on a tear. Biggest gainer in the S&P 500 today. And it's up for its best day since 2009. Shares up as much as 19%."
The speaker highlights upbeat earnings news from Intuitive Surgical (ISRG), noting an upgraded forecast for its Da Vinci procedure growth. The commentary underscores the strong market performance with shares up 19% and being the S&P 500's biggest gainer for the day.
Rule Breaker Trade Call: Intuitive Surgical
"I would say a great example. This is a lesser known company, but Intuitive Surgical, which is basically a company in the rule breakers service that is converting all of the past surgery, human driven, human hands to minimally invasive robot assisted surgery. And when I first recommended Intuitive Surgical, it was trading at 71 times earnings... But now it's up more than 70, actually closer to 90 times in value from that point."
David Gardner highlights Intuitive Surgical as an exemplar rule breaker stock. Despite trading at high earnings multiples (71x initially), its strong fundamentals and innovative approach in robotic surgery have driven its significant outperformance. He uses this as a buy signal, urging investors to consider overweighting this type of premium stock when supported by other rule breaker traits.
Intuitive Surgical: Dominant Force in Robotic Surgery
"If Tiger were a stock, I'd still be holding it. Intuitive Surgical, with its groundbreaking DaVinci surgical robot, has no clear competitor – there's simply no Pepsi to its Coke."
David Gardner identifies Intuitive Surgical as a rule breaker stock with a sustainable, dominant competitive advantage in the field of robot-assisted surgery. He emphasizes its unique market position, comparing it to the 'Coca-Cola' of its industry, and highlights its long-term potential for multibagger returns.